|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
|
2
|
Murer H, Forster I and Biber J: The sodium
phosphate cotransporter family SLC34. Pfugers Arch. 447:763–767.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zheng X, Kammerer CM, Cox LA, Morrison A,
Turner ST and Ferrell RE: Association of SLC34A2 variation and
sodium-lithium countertransport activity in humans and baboons. Am
J Hypertens. 22:288–293. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lituiev DS and Kiyamova RG: Mutations in
the gene of human type IIb sodium-phosphate cotransporter SLC34A2.
Biopolym Cell. 26:13–22. 2010. View Article : Google Scholar
|
|
5
|
Tenenhouse HS: Phosphate transport:
Molecular basis, regulation and pathophysiology. J Steroid Biochem
Mol Biol. 103:572–577. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu H, Bai L, Collins JF and Ghishan FK:
Molecular cloning, functional characterization, tissue
distribution, and chromosomal localization of a human, small
intestinal sodium-phosphate (Na+-Pi) transporter (SLC34A2).
Genomics. 62:281–284. 1999. View Article : Google Scholar
|
|
7
|
Corut A, Senyigit A, Ugur S, Altin S,
Ozcelik U, Calisir H, Yildirim Z, Gocmen A and Tolun A: Mutations
in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly
associated with testicular microlithiasis. Am J Hum Genet.
79:650–656. 2006. View
Article : Google Scholar
|
|
8
|
Vachon L, Fareau GE, Wilson MG and Chan
LS: Testicular microlithiasis in patients with Down syndrome. J
Pediatr. 149:233–236. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hernando N, Sheikh S, Karim-Jimenez Z,
Galliker H, Forgo J and Biber J: Asymmetrical targeting of type II
Na-P(i) cotransporters in renal and intestinal epithelial cell
lines. Am J Physiol Renal Physiol. 278:F361–F368. 2000.PubMed/NCBI
|
|
10
|
Cerri MF, Rezende LC, Paes FM, Silva IV
and Rangel LBA: The cotransporter NaPi-IIb: characteristics,
regulation and its role in carcinogenesis. Applied Cancer Res.
30:197–203. 2010.
|
|
11
|
Shibasaki Y, Etoh N and Hayasaka M:
Targeted deletion of the tybe IIb Na+dependent
Pi-co-transporter, NaPi-IIb, results in early embryonic lethality.
Biochem Biophys Res Commun. 381:482–486. 2009.PubMed/NCBI
|
|
12
|
Kopantzev EP, Monastyrskaya GS,
Vinogradova TV, et al: Differences in gene expression levels
between early and later stages of human lung development are
opposite to those between normal lung tissue and non-small lung
cell carcinoma. Lung Cancer. 62:23–34. 2008. View Article : Google Scholar
|
|
13
|
el-Deiry WS, Nelkin BD, Celano P, Yen RW,
Falco JP, Hamilton SR and Baylin SB: High expression of the DNA
methyltransferase gene characterizes human neoplastic cells and
progression stages of colon cancer. Proc Natl Acad Sci USA.
88:3470–3474. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lengauer C, Kinzler KW and Vogelstein B:
DNA methylation and genetic instability in colorectal cancer cells.
Proc Natl Acad Sci USA. 94:2545–2550. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu H, Kho AT, Kohane IS and Sun Y:
Predicting survival within the lung cancer histopathological
hierarchy using a multi-scale genomic model of development. PLoS
Med. 3:e2322006. View Article : Google Scholar
|
|
16
|
Ramirez MI, Pollack L, Millien G, Cao YX,
Hinds A and Williams MC: The alpha-isoform of caveolin-1 is a
marker of vasculogenesis in early lung development. J Histochem
Cytochem. 50:33–42. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hnasko R and Ben-Jonathan N: Developmental
regulation of PV-1 in rat lung: association with the nuclear
envelope and limited colocalization with Cav-1. Am J Physiol Lung
Cell Mol Physiol. 288:L275–L284. 2005. View Article : Google Scholar
|
|
18
|
Wiliams TM and Lisanti MP: Caveolin-1 in
oncogenic transformation, cancer, and metastasis. Am J Physiol Cell
Physiol. 288:C494–C506. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sunaga N, Miyajima K, Suzuki M, Sato M,
White MA, Ramirez RD, Shay JW, Gazdar AF and Minna JD: Different
roles for caveolin-1 in the development of non-small cell lung
cancer versus small cell lung cancer. Cancer Res. 64:4277–4285.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bélanger MM, Gaudreau M, Roussel E and
Couet J: Role of caveolin-1 in etoposide resistance development in
A549 lung cancer cells. Cancer Biol Ther. 3:954–959.
2004.PubMed/NCBI
|
|
21
|
Traebert M: Expression of type II Na-P(i)
cotransporterin alveolar type II cells. Am J Physiol.
277:L868–L873. 1999.PubMed/NCBI
|
|
22
|
Griffiths MJ, Bonnet D and Janes SM: Stem
cells of the alveolar epithelium. Lancet. 366:249–260. 2005.
|
|
23
|
Kinnard WV, Tuder R, Papst P and Fisher
JH: Regulation of alveolar type II cell differentiation and
proliferation in adult rat lung explants. Am J Respir Cell Mol
Biol. 11:416–425. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ten Have-Opbroek AA, Benfield JR, Hammond
WG and Dijkman JH: Alveolar stem cells in canine bronchial
carcinogenesis. Cancer Lett. 101:211–217. 1996.PubMed/NCBI
|
|
25
|
Ten Have-Opbroek AA, Benfield JR, van
Krieken JH and Dijkman JH: The alveolar type II cell is a
pluripotential stem cell in the genesis of human adenocarcinomas
and squamous cell carcinomas. Histol Histopathol. 12:319–336.
1997.PubMed/NCBI
|
|
26
|
Kitinya JN, Sueishi K, Tanaka K and
Katsuda Y: Immunoreactivity of surfactant-apoprotein
adenocarcinomas, large cell and small cell carcinomas of the lung.
Acta Pathol Jpn. 36:1271–1278. 1986.PubMed/NCBI
|
|
27
|
Gazdar FA, Linnoila R, Kurita Y, et al:
Peripheral airway cell differentiation in human lung cancer. Cancer
Res. 50:5481–5487. 1990.PubMed/NCBI
|
|
28
|
Holm BA, Matalon S, Finkelstein JN and
Notter RH: Type II pneumocyte changes during hyperoxic lung injury
and recovery. J Appl Physiol. 1985.65:2672–2678. 1988.PubMed/NCBI
|
|
29
|
Kim CF, Jackson EL, Woolfenden AE, et al:
Identification of bronchioalveolar stem cells in normal lung and
lung cancer. Cell. 121:823–835. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu CX, Jin H, Chung YS, et al: Low dietary
inorganic phosphate affects the lung growth of developing mice. J
Vet Sci. 10:105–113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsao MS, Zhu H and Viallet J: Autocrine
growth loop of the epidermal growth factor receptor in normal and
immortalized human bronchial epithelial cells. Exp Cell Res.
223:268–273. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lieber M, Smith B, Szakal A, Nelson-Rees W
and Todaro G: A continuous tumor-cell line from a human lung
carcinoma with properties of type II alveolar epithelial cells. Int
J Cancer. 17:62–70. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu Q, Lu A, Xiao G, et al: Transcriptional
profiling of midgut immunity response and degeneration in the
wandering silkworm, Bombyx mori. Plos one. 7:e437692012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hill LD, Sun L, Leuschen MP and Zach TL:
C3 synthesis by A549 alveolar epithelial cells is increased by
interferon-γ and dexamethasone. Immunology. 79:236–240.
1993.PubMed/NCBI
|
|
35
|
Neal C, Neal M and Wickham H: Phosphate
measurement in natural waters: two examples of analytical problems
associated with silica interference using phosphomolybdic acid
methodologies. Sci Total Environ. 252:511–512. 2000. View Article : Google Scholar
|
|
36
|
Gałeza M, Zebracka J, Szpak-Ulczok S, et
al: Expression of selected genes involved in transport of ions in
papillary thyroid carcinoma. Endokrynol Pol. 57:26–31. 2006.(In
Polish).
|
|
37
|
Blanchard A, Shiu R, Booth S, et al: Gene
expression profiling of early involuting mammary gland reveals
novel genes potentially relevant to human breast cancer. Front
Biosci. 12:2221–2232. 2007. View
Article : Google Scholar
|
|
38
|
Yin BW, Kiyamova R, Chua R, Caballero OL,
et al: Monoclonal antibody MX35 detects the membrane transporter
NaPi2b (SLC34A2) in human carcinomas. Cancer Immun.
8:32008.PubMed/NCBI
|
|
39
|
Cuzin M: DNA chips: a new tool for genetic
analysis and diagnostics. Transfus Clin Biol. 8:291–296. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Strunk RC, Eidlen DM and Mason RJ:
Pulmonary alveolar type II epithelial cells synthesize and secrete
proteins of the classical and alternative complement pathways. J
Clin Invest. 81:1419–1426. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Niculescu F, Rus HG, Retegan M and Vlaicu
R: Persistent complement activation on tumor cells in breast
cancer. Am J Pathol. 140:1039–1043. 1992.PubMed/NCBI
|
|
42
|
Magyarlaki T, Mosolits S, Baranyay F and
Buzogany I: Immunohistochemistry of complement response on human
renal cell carcinoma biopsies. Tumori. 82:473–479. 1996.PubMed/NCBI
|
|
43
|
Clynes RA, Towers TL, Presta LG and
Ravetch JV: Inhibitory Fc receptors modulate in vivo cytoxicity
against tumor targets. Nat Med. 6:443–446. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kierszenbaum F and Budzko DB: Cytotoxic
effects of normal sera on lymphoid cells. I. Antibody-independent
killing of heterologous thymocytes by guinea pig, rabbit, and human
sera: Role of the alternative pathway of complement activation.
Cell Immunol. 29:137–146. 1977.
|
|
45
|
Rothman BL, Despins AW and Kreutzer DL:
Cytokine regulation of C3 and C5 production by the human type II
pneumocyte cell line, A549. J Immunol. 145:592–598. 1990.PubMed/NCBI
|
|
46
|
Rothman BL, Merrow M, Despins A, Kennedy T
and Kreutzer DL: Effect of lipopolysaccharide on C3 and C5
production by human lung cells. J Immunol. 143:196–202.
1989.PubMed/NCBI
|
|
47
|
Duerst RE, Ryan DH and Frantz CN:
Variables affecting the killing of cultured human neuroblastoma
cells with monoclonal antibody and complement. Cancer Res.
46:3420–3425. 1986.PubMed/NCBI
|
|
48
|
Jima DD, Shaha RN and Orcutta TM: Enhanced
transcription of complement and coagulation genes in the absence of
adaptive immunity. Mol Immunol. 46:1505–1516. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hickman-Davis JM, Fang FC and Nathan C:
Lung surfactant and reactive oxygen-nitrogen species: antimicrobial
activity and host-pathogen interactions. Am J Physiol Lung Cell Mol
Physiol. 281:L517–L523. 2001.PubMed/NCBI
|
|
50
|
Malmsten M, Lassen B, James MV and Nilsson
UR: Adsorption of complement proteins C3 and C1q. J Colloid
Interface Sci. 178:123–134. 1996. View Article : Google Scholar
|
|
51
|
Mold C: Effect of membrane phospholipids
on activation of the alternative complement pathway. J Immunol.
143:1663–1668. 1989.PubMed/NCBI
|
|
52
|
Takeda E, Yamamoto H, Nashiki K, Sato T,
Arai H and Taketani Y: Inorganic phosphate homeostasis and the role
of dietary phosphorus. J Cell Mol Med. 8:191–200. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Furukawa T, Sunamura M, Motoi F, Matsuno S
and Horii A: Potential tumor suppressive pathway involving
DUSP6/MKP-3 in pancreatic cancer. Am J Pathol. 162:1807–1815. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhang Z, Kobayashi S, Borczuk AC, Leidner
RS, Laframboise T, Levine AD and Halmos B: Dual specificity
phosphatase 6 (DUSP6) is an ETS-regulated negative feedback
mediator of oncogenic ERK signaling in lung cancer cells.
Carcinogenesis. 31:577–586. 2010.
|
|
55
|
Li T, Yang W and Li M: Expression of
selenium binding protein 1 characterizes intestinal cell maturation
and predicts survival for patients with colorectal cancer. Mol Nutr
Food Res. 52:1289–1299. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Huang KC, Park DC, Ng SK, et al: Selenium
binding protein 1 in ovarian cancer. Int J Cancer. 118:2433–2440.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chen G, Wang H and Miller CT: Reduced
selenium-binding protein 1 expression is associated with poor
outcome in lung adenocarcinomas. J Pathol. 202:321–329. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yang M and Sytkowski AJ: Differential
expression and androgen regulation of the human selenium-binding
protein gene hSP56 in prostate cancer cells. Cancer Res.
58:3150–3153. 1998.PubMed/NCBI
|
|
59
|
Parikh H, Carlsson E, Chutkow WA and
Johansson LE: TXNIP regulates peripheral glucose metabolism in
humans. PLoS Med. 4:e1582007. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Capuano P, Bacic D and Stange G:
Expression and regulation of the renal Na/phosphate cotransporter
NaPi-IIa in a mouse model deficient for the PDZ protein PDZK1.
Pflugers Arch. 449:392–402. 2005. View Article : Google Scholar : PubMed/NCBI
|
